Cytoart’s antibody development platform focuses on targeting the scFV region on CAR-T cells. scFV target detection is a valuable tool Cytoart implements in the development of antibodies for CAR T-cell detection reagents. Using scFV for target detection for CAR T-cell therapy offers several benefits:

1. High Specificity: Our ScFV-based antibodies are engineered to target the specific antigen, ensuring correct target binding and reducing off-target complications.
2. Sensitivity: scFV target detection is highly sensitive, allowing for the detection of low levels of CAR T-cells in samples.
3. Real-time Monitoring: ScFV target detection enables real-time monitoring of CAR T-cell activity and distribution in sample.
4. Versatility: ScFV target detection can be applied to various types of studies involving CAR T-cells.